Platelet Function Testing in Target Safety Assessment
Adverse findings in non-clinical safety/toxicity testing continue to be a major reason for failure and/or complexity in drug projects. Since primary target-related toxicity plays a role in a significant proportion of these failures, an in-depth assessment of potential adverse consequences of target modulation can provide an important de-risking step in the discovery phase. Target Safety […]
